<?xml version="1.0" encoding="UTF-8"?>
<p id="Par31">All research was performed in accordance with relevant guidelines/regulations. Informed consent was obtained from all participants who provided blood plasma samples from which new HIV-1 sequences were generated (informed consent was not required for subjects whose sequences were obtained from LANL). Plasma samples used to generate the new sequences were obtained from on-going or concluded studies that were also approved by KEMRI/SERU (SERU 3747, 3280 and 3520, and SSC 894). The current study is part of a parent protocol that was reviewed and approved by the Kenya Medical Research Institute (KEMRI) Scientific and Ethics Review Unit (SERU 3547).</p>
